GINA MOWER: Open Payments
NPI 1104037514 · SEATTLE, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,355 in 66 payments from 16 companies in 2025. Trend: 2023 $1,153 · 2024 $1,586 · 2025 $1,355
Food & beverage: $1,283Education: $72
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $402 |
| ABBVIE INC. | 6 | $168 |
| PFIZER INC. | 11 | $139 |
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| SANOFI-AVENTIS U.S. LLC | 1 | $72 |
| Incyte Corporation | 3 | $68 |
| Organogenesis Inc. | 3 | $68 |
| Regeneron Healthcare Solutions, Inc. | 2 | $60 |
| GENZYME CORPORATION | 2 | $49 |
| UCB, Inc. | 2 | $44 |
Products named: TREMFYA, SKYRIZI, DUPIXENT, COSENTYX, CIBINQO, OPZELURA, Bimzelx, Sotyktu.
Industry payments across WA — which companies pay providers there.
